- Opportunity and Forecast, 2016 - 2025
Enzymes act as catalysts that increase the rate of the chemical reaction, and are extracted from plants and animals. They play a significant role in digestion of food and deliver nutrients to the blood, with the help of enzymes in food. With advancement in technology, including genetic engineering and protein engineering, manufacturers are developing required amount of enzymes in food products. They are also investing in R&D activities to manufacture enzymes for various applications. Manufactures are inclined towards production of enzymes from microorganisms as compared to traditional commercial production techniques.
The global enzymes market is driven by expansion of food & beverages industry, development of enzyme engineering, and growth in application scope in biofuels. Lack of standardized guidelines is a major factor that restrains the market growth. Technological advancements and rise in demand for high-quality meat provide new opportunities in the industry.
The global enzymes market is segmented on the basis of product type, application, and geography. Based on product type, the market is classified into proteases, lipases, carbohydrases, polymerases, and nucleases. Based on application, it is divided into detergents, animal feed, food & beverages, and biofuels. Geographically, it is analyzed across North America, Latin America, Asia-Pacific, Europe, and Middle East and Africa.
Key players operating in this market include Novozymes, DSM, Danisco, BASF, Royal DSM N.V, Chr. Hansen, Roche, Enmex, Lonza Group, Adisseo, and others. These players have adopted developmental strategies, including collaborations, new product launches, partnerships, mergers & acquisitions, joint ventures, expansion, and others, to strengthen their position and sustain in the global industry.
The global monoclonal antibody market was valued at $76,899 million in 2014 and is estimated to reach $214,922 million by 2025, registering a CAGR of 9.8% from 2018 to 2025. Read More >>